Bausch Health Companies Inc. (TSX:BHC)
9.04
-0.30 (-3.21%)
Oct 6, 2025, 4:00 PM EDT
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $2.53B USD in the quarter ending June 30, 2025, with 5.29% growth. This brings the company's revenue in the last twelve months to $9.86B, up 7.13% year-over-year. In the year 2024, Bausch Health Companies had annual revenue of $9.63B with 9.91% growth.
Revenue (ttm)
$9.86B
Revenue Growth
+7.13%
P/S Ratio
0.26
Revenue / Employee
$476.23K
Employees
20,700
Market Cap
3.45B CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Curaleaf Holdings | 1.75B |
Green Thumb Industries | 1.57B |
Trulieve Cannabis | 1.62B |
dentalcorp Holdings | 1.62B |
Sienna Senior Living | 929.68M |
WELL Health Technologies | 1.12B |
Cronos Group | 177.69M |
Extendicare | 1.51B |
Bausch Health Companies News
- 6 days ago - Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV - Accesswire
- 6 days ago - Bausch Health to Announce Third Quarter 2025 Results on October 29 - Accesswire
- 7 days ago - Bausch Health (BHC) Launches OraTalks Podcast to Address Dental Industry Issues - GuruFocus
- 7 days ago - Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry - Accesswire
- 11 days ago - BHC Makes Notable Cross Below Critical Moving Average - Nasdaq
- 11 days ago - Bausch + Lomb Breaks Below 200-Day Moving Average - Notable for BLCO - Nasdaq
- 13 days ago - Bausch Health (BHC) and Teva Accused of Antitrust Violations Over Xifaxan - GuruFocus
- 25 days ago - Bausch Health: Repricing Continues As Deleveraging Gains Traction - Seeking Alpha